Journal
THERAPEUTIC DELIVERY
Volume 9, Issue 2, Pages 121-136Publisher
FUTURE SCI LTD
DOI: 10.4155/tde-2017-0102
Keywords
clinical trial registrations; manufacture; market uptake; mesh/jet; nebulizer; popularity
Categories
Ask authors/readers for more resources
In the 24 years since first being marketed, the mesh nebulizer has been developed by five main manufacturers into a viable solution for the delivery of high-value nebulized drugs. Mesh nebulizers provide increased portability, convenience and energy efficiency along with similar lung deposition and increased ease of use compared with jet nebulizers. An analysis of EU and US clinical trial databases has shown that mesh nebulizers are now preferred over jet nebulizers for clinical trials sponsored by pharmaceutical companies. The results show a strong preference for the use of mesh nebulizers in trials involving high cost and niche therapy areas. Built-in capability to optimize the way patients use their mesh nebulizer and manage their disease will further increase uptake.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available